nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Community-wide HIV testing, linkage case management, and defaulter tracing in Bukoba, Tanzania: pre-intervention and post-intervention, population-based survey evaluation
|
Steiner, Claire |
|
|
7 |
10 |
p. e699-e710 |
artikel |
2 |
Data-driven HIV programming to maximise health benefits
|
Barnabas, Ruanne V |
|
|
7 |
10 |
p. e662-e663 |
artikel |
3 |
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
|
Calmy, Alexandra |
|
|
7 |
10 |
p. e677-e687 |
artikel |
4 |
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial
|
Venter, Willem D F |
|
|
7 |
10 |
p. e666-e676 |
artikel |
5 |
Health systems software factors and their effect on the integration of sexual and reproductive health and HIV services
|
Mayhew, Susannah H |
|
|
7 |
10 |
p. e711-e720 |
artikel |
6 |
Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies
|
Rutstein, Sarah E |
|
|
7 |
10 |
p. e721-e730 |
artikel |
7 |
INSTIs and weight gain in pregnancy
|
Bengtson, Angela M |
|
|
7 |
10 |
p. e663-e665 |
artikel |
8 |
Public Health England's political end
|
The Lancet HIV, |
|
|
7 |
10 |
p. e661 |
artikel |
9 |
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
|
Baden, Lindsey R |
|
|
7 |
10 |
p. e688-e698 |
artikel |